332 related articles for article (PubMed ID: 18226593)
21. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
23. Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague-Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management.
Sengupta S; Arshad M; Sharma S; Dubey M; Singh MM
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):421-9. PubMed ID: 15876407
[TBL] [Abstract][Full Text] [Related]
24. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
[TBL] [Abstract][Full Text] [Related]
25. High bone matrix turnover predicts blood levels of lead among perimenopausal women.
Machida M; Sun SJ; Oguma E; Kayama F
Environ Res; 2009 Oct; 109(7):880-6. PubMed ID: 19595303
[TBL] [Abstract][Full Text] [Related]
26. Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.
Sillem M; Parviz M; Woitge HW; Kiesel L; Ulrich U; von Holst T; Runnebaum B; Ziegler R; Seibel MJ
Exp Clin Endocrinol Diabetes; 1999; 107(6):379-85. PubMed ID: 10543415
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
28. [Bone mineral density in patients with rheumatoid arthritis].
Gukasian DA; Nasonov EL; Balabanova RM; Smirnov AV
Ter Arkh; 2001; 73(12):68-70. PubMed ID: 11858115
[TBL] [Abstract][Full Text] [Related]
29. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah S; Chow SK; Goh EM
Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
[TBL] [Abstract][Full Text] [Related]
30. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
[TBL] [Abstract][Full Text] [Related]
31. [Early, noninvasive diagnostic of osteoporosis in men].
Lepiarz-Rusek W; Kokocińska D
Przegl Lek; 2005; 62(7):641-9. PubMed ID: 16463693
[TBL] [Abstract][Full Text] [Related]
32. Bone mass and turnover in fibromyalgia.
Jacobsen S; Gam A; Egsmose C; Olsen M; Danneskiold-Samsøe B; Jensen GF
J Rheumatol; 1993 May; 20(5):856-9. PubMed ID: 8336312
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and risk factors of osteoporosis in female SLE patients-extended report.
Almehed K; Forsblad d'Elia H; Kvist G; Ohlsson C; Carlsten H
Rheumatology (Oxford); 2007 Jul; 46(7):1185-90. PubMed ID: 17500075
[TBL] [Abstract][Full Text] [Related]
34. Bone metabolism and mineral density in patients with beta-thalassemia major.
Dundar U; Kupesiz A; Ozdem S; Gilgil E; Tuncer T; Yesilipek A; Gultekin M
Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474
[TBL] [Abstract][Full Text] [Related]
35. Bone metabolism in postmenopausal women with lumbar spinal stenosis: analysis of bone mineral density and bone turnover markers.
Kim HJ; Lee HM; Kim HS; Park JO; Moon ES; Park H; Park SY; Moon SH
Spine (Phila Pa 1976); 2008 Oct; 33(22):2435-9. PubMed ID: 18923320
[TBL] [Abstract][Full Text] [Related]
36. Rheumatoid arthritis: evidence for bone loss in premenopausal women.
Tourinho TF; Stein A; Castro JA; Brenol JC
J Rheumatol; 2005 Jun; 32(6):1020-5. PubMed ID: 15940761
[TBL] [Abstract][Full Text] [Related]
37. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
Shaarawy M; El-Mallah SY; Seoudi S; Hassan M; Mohsen IA
Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
[TBL] [Abstract][Full Text] [Related]
38. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
39. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
40. Increased bone turnover during the third trimester of pregnancy and decreased bone mineral density after parturition in adolescents as compared to age-matched control patients.
Silva HG; Tórtora RP; Farias ML
Gynecol Endocrinol; 2005 Sep; 21(3):174-9. PubMed ID: 16335911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
